Earnings summaries and quarterly performance for SONO TEK.
Executive leadership at SONO TEK.
R. Stephen Harshbarger
Detailed
Chief Executive Officer and President
CEO
CC
Christopher C. Cichetti
Detailed
Chief Operating Officer
CL
Christopher L. Coccio
Detailed
Executive Chairman
MT
Maria T. Kuha
Detailed
Vice President, Manufacturing Operations, Procurement & Logistics
SJ
Stephen J. Bagley
Detailed
Chief Financial Officer
Board of directors at SONO TEK.
Research analysts who have asked questions during SONO TEK earnings calls.
RR
Richard Ryan
Oak Ridge Financial
5 questions for SOTK
Also covers: GHM, INTT
BN
Bill Nicklin
Bill White Insights
4 questions for SOTK
EJ
Edward Jackson
Northland Securities, Inc.
3 questions for SOTK
Also covers: ALNT, ALTG, AMPX +8 more
AN
Andy Newby
Newby Investments
2 questions for SOTK
DR
Dick Ryan
Oak Ridge Financial
2 questions for SOTK
DB
Daniel Bouchin
Private Investor
1 question for SOTK
TJ
Ted Jackson
Northland Securities, Inc.
1 question for SOTK
Also covers: ALTG, CNH, HY +6 more
Recent press releases and 8-K filings for SOTK.
Sono-Tek Reports Fiscal Third Quarter and Nine-Month Fiscal 2026 Financial Results
SOTK
Earnings
Guidance Update
- Sono-Tek Corporation reported net sales of $5.0 million for the third quarter of fiscal 2026, marking its seventh consecutive quarter with revenue exceeding $5 million.
- For the third quarter, gross profit increased 7% to $2.5 million, with the gross margin expanding to 50% from 45% in the prior-year quarter, while net income rose 24% to $340 thousand, or $0.02 per diluted share.
- The company's backlog reached a record $12.3 million, reflecting a 16% year-over-year increase and 9% sequential growth.
- Sono-Tek reiterated its full-year fiscal 2026 guidance, anticipating modest revenue growth, driven by continued strength in the medical market and high-ASP production systems, despite declines in alternative energy sales.
Jan 13, 2026, 12:10 PM
Sono-Tek Reports Fiscal Third Quarter and Nine-Month 2026 Financial Results
SOTK
Earnings
Guidance Update
- Sono-Tek reported Net Sales of $5.0 million for the third quarter of fiscal year 2026, a 4% decrease compared to the prior-year period, marking the seventh consecutive quarter with revenue exceeding $5 million.
- Net Income for Q3 FY2026 increased 24% to $340 thousand, or $0.02 per diluted share.
- For the first nine months of fiscal year 2026, Net Sales totaled $15.3 million, which was essentially flat year-over-year, while Net Income increased 32% to $1.25 million, or $0.08 per diluted share.
- The company's gross margin expanded to 50% in Q3 and 51% year-to-date, reflecting a strategy to prioritize higher-ASP production systems.
- Sono-Tek ended the quarter with a record backlog of $12.26 million and $11.7 million in cash, cash equivalents, and marketable securities, with no outstanding debt, and reiterated its full fiscal year 2026 guidance anticipating modest revenue growth.
Jan 13, 2026, 12:00 PM
Sono-Tek Reports Fiscal Second Quarter and Record First Half 2026 Financial Results
SOTK
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Sono-Tek Corporation reported net sales of $5.163 million for the second quarter of fiscal year 2026, marking its sixth consecutive quarter of revenue over $5 million.
- For Q2 FY26, net income increased 24% to $424 thousand, or $0.03 per share, compared to the prior year.
- The company achieved record first-half fiscal 2026 revenue of $10.30 million and a 35% increase in net income to $909 thousand, or $0.06 per share.
- As of August 31, 2025, Sono-Tek held $10.6 million in cash, cash equivalents, and marketable securities with no outstanding debt.
- Backlog increased 50% sequentially to $11.21 million from $7.48 million at the end of Q1 FY26, reflecting new order momentum from the medical market. The company updated its FY26 guidance to anticipate modest revenue growth, driven by increasing demand in the medical device market.
Nov 12, 2025, 9:30 PM
SOTK Reports Record First-Half Fiscal 2026 Revenue and Increased Guidance
SOTK
Earnings
Guidance Update
New Projects/Investments
- SOTK reported record first-half fiscal 2026 revenue of $10,300,000 and net income of $909,000, or $0.06 per share, marking a 36% year-over-year increase in net income.
- The company is experiencing strong momentum in the medical device industry, with second-quarter medical market sales increasing 150% year-over-year to $1,000,000, which is helping to mitigate an anticipated decline in clean energy orders.
- SOTK has increased its full fiscal year guidance to reflect modest revenue growth, balancing caution regarding clean energy and tariff policies with growing demand from the medical device industry.
- The company maintains a strong balance sheet with a backlog of $11,200,000 and $10,600,000 in cash with no debt as of August 31, 2025.
- Strategic investments in its Forward Deployed Engineering (FDE) model and product line expansion, particularly in the semiconductor market's move to 300 millimeter environments, are expected to drive future growth and margin expansion.
Oct 14, 2025, 2:30 PM
Sono-Tek receives $2.8 million order for medical device coating systems
SOTK
New Projects/Investments
Revenue Acceleration/Inflection
- Sono-Tek Corporation announced it received a purchase order valued at over $2.8 million from a major U.S.-based medical device manufacturer.
- The order, placed by an existing customer ramping up production, includes multiple advanced ExactaCoat MD (Medical Device) systems with expanded capabilities.
- Deliveries of the new equipment are expected to begin in early 2026 and be completed within the first half of 2026.
- This order is from a different customer than the $5 million medical device order announced last month, further broadening Sono-Tek's high-value opportunities.
Oct 14, 2025, 11:10 AM
Sono-Tek Reports Q2 and First Half Fiscal Year 2026 Results
SOTK
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Sono-Tek Corporation reported second quarter fiscal year 2026 net sales of $5.163 million and a 24% increase in net income to $424 thousand.
- For the first half of fiscal year 2026, the company achieved record revenue of $10.30 million and a 35% increase in net income to $909 thousand.
- Sales in the Medical market increased by 150% year-over-year to $1.00 million in Q2 FY2026, contributing to a 50% sequential increase in backlog to $11.21 million.
- The company updated its FY2026 guidance, anticipating modest revenue growth with increasing demand in the medical device market.
Oct 14, 2025, 11:10 AM
Sono-Tek Reports Fiscal Second Quarter and First Half 2026 Financial Results
SOTK
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Net sales for Q2 fiscal year 2026 were $5.163 million, a slight increase year-over-year, contributing to record first half fiscal 2026 revenue of $10.30 million.
- Net income for Q2 fiscal year 2026 rose 24% to $424 thousand, or $0.03 per share, with first half net income increasing 35% to $909 thousand, or $0.06 per share.
- The company's backlog strengthened, increasing 50% sequentially to $11.21 million by the end of Q2 FY26, driven by new orders from the medical market.
- Sales in the Medical market surged 150% year-over-year to $1.00 million in Q2 FY26.
- Sono-Tek updated its FY26 guidance, now projecting modest revenue growth for the full fiscal year.
Oct 14, 2025, 11:09 AM
Sono-Tek Secures $2.8 Million Medical Device Order
SOTK
New Projects/Investments
Revenue Acceleration/Inflection
- Sono-Tek Corporation (SOTK) has received a purchase order valued at over $2.8 million from a major U.S.-based medical device manufacturer.
- The order includes multiple advanced ExactaCoat MD (Medical Device) systems, with deliveries anticipated to commence in early calendar year 2026 and conclude within the first half of 2026.
- This order is from a different customer than the $5 million medical device order announced last month, reinforcing Sono-Tek's strong position and expanding opportunities in the medical device sector.
Oct 13, 2025, 11:00 AM
Quarterly earnings call transcripts for SONO TEK.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more